These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18989725)

  • 1. International randomized trials' attention to locoregional breast cancer control and promise of personal genomics and whole-genome scans for personalized approaches.
    Zografos G; Roukos DH
    Ann Surg Oncol; 2009 Jan; 16(1):222-3. PubMed ID: 18989725
    [No Abstract]   [Full Text] [Related]  

  • 2. Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer.
    Roukos DH
    J Clin Oncol; 2009 Mar; 27(8):1337-8; author reply 1338-9. PubMed ID: 19188673
    [No Abstract]   [Full Text] [Related]  

  • 3. Linking contralateral breast cancer with genetics.
    Roukos DH
    Radiother Oncol; 2008 Feb; 86(2):139-41. PubMed ID: 18237805
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomics and challenges toward personalized breast cancer local control.
    Roukos DH; Lykoudis E; Liakakos T
    J Clin Oncol; 2008 Sep; 26(26):4360-1; author reply 4361-2. PubMed ID: 18779627
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.
    Ziogas D; Roukos DH
    Ann Surg Oncol; 2009 Jul; 16(7):1771-82. PubMed ID: 19322611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine.
    Roukos DH
    Ann Surg Oncol; 2009 Mar; 16(3):772-3. PubMed ID: 18726130
    [No Abstract]   [Full Text] [Related]  

  • 7. Can lifestyle choices influence breast cancer risk and prognosis?
    J Support Oncol; 2007 Feb; 5(2):60. PubMed ID: 17348355
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular predictors of locoregional recurrence in breast cancer: ready for prime time?
    Haffty BG; Buchholz TA
    J Clin Oncol; 2010 Apr; 28(10):1627-9. PubMed ID: 20194835
    [No Abstract]   [Full Text] [Related]  

  • 9. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding tumor profiling and assessing treatment.
    Hyams DM
    Manag Care; 2008 Jul; 17(7 Suppl 7):4-8; discussion 17-8. PubMed ID: 19093336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
    J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional disease control and breast conservation in early breast cancer.
    Semin Surg Oncol; 1992; 8(3):111-76. PubMed ID: 1496218
    [No Abstract]   [Full Text] [Related]  

  • 13. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.
    Taylor ME; Haffty BG; Rabinovitch R; Arthur DW; Halberg FE; Strom EA; White JR; Cobleigh MA; Edge SB
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):997-1002. PubMed ID: 19251087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health literacy and cancer risk perception: implications for genomic risk communication.
    Brewer NT; Tzeng JP; Lillie SE; Edwards AS; Peppercorn JM; Rimer BK
    Med Decis Making; 2009; 29(2):157-66. PubMed ID: 19050227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome analysis personalizes breast cancer treatment.
    Cancer Discov; 2012 Dec; 2(12):OF6. PubMed ID: 23230207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer. Advances in diagnosis and treatment.
    Mayo Clin Health Lett; 2009 Jun; Suppl():1-8. PubMed ID: 19705515
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast conservation therapy for patients with locally advanced breast cancer.
    Alm El-Din MA; Taghian AG
    Semin Radiat Oncol; 2009 Oct; 19(4):229-35. PubMed ID: 19732687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.
    Waltersson MA; Askmalm MS; Nordenskjöld B; Fornander T; Skoog L; Stål O
    Int J Oncol; 2009 Feb; 34(2):441-8. PubMed ID: 19148479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary systemic therapy in breast cancer: past lessons and new approaches.
    Herold CI; Marcom PK
    Cancer Invest; 2008 Dec; 26(10):1052-9. PubMed ID: 19093262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.